About EyeGate Pharma
EyeGate Pharma is a privately held, specialty pharmaceutical company dedicated to developing therapeutics for treating ocular disorders. Its proprietary, non-invasive EyeGate® II Delivery System (EGDS) is designed to achieve optimal therapeutic levels of drug in the anterior and posterior segments of the eye, while at the same time minimizing systemic distribution.
The EyeGate® II Delivery System overcomes the shortcomings of current dosing approaches. Topical applications of therapeutics may have issues of insufficient ocular exposure, systemic exposure, high dosing frequency, and compliance. Injections/implants present potential safety risks. The EGDS doses substantially more drug more quickly, which can accelerate the onset of action and may limit safety risks because it may require less frequent dosing than conventional methods.